Although LOXL2 has been implicated in the progression of multiple solid tumors (54) and is overexpressed in prostate cancer (53), few studies have reported a specific role for LOXL2 in prostate CAF function (40, 79). The gene discussed is LOXL2; the disease is prostate carcinoma.